A Systematic Review and Meta-Analysis Including 354 Patients from 13 Studies of Intravascular Lithotripsy for the Treatment of Underexpanded Coronary Stents.

calcified lesions intravascular lithotripsy percutaneous coronary interventions stent underexpansion

Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 10 2023
Historique:
received: 20 01 2023
revised: 25 07 2023
accepted: 30 07 2023
medline: 22 9 2023
pubmed: 24 8 2023
entrez: 23 8 2023
Statut: ppublish

Résumé

Calcified coronary plaque (CCP) represents a challenging scenario for interventional cardiologists. Stent underexpansion (SU), often associated with CCP, can predispose to stent thrombosis and in-stent restenosis. To date, SU with heavily CCP can be addressed using very high-/high-pressure noncompliant balloons, off-label rotational atherectomy/orbital atherectomy, excimer laser atherectomy, and intravascular lithotripsy (IVL). In this meta-analysis, we investigated the success rate of IVL for the treatment of SU because of CCP. Studies and case-based experiences reporting on the use of IVL strategy for treatment of SU were included. The primary end point was IVL strategy success, defined as the adequate expansion of the underexpanded stent. A metanalysis was performed for the main focuses to calculate the proportions of procedural success rates with corresponding 95% confidence intervals (CIs). Random-effects models weighted by inverse variance were used because of clinical heterogeneity. This meta-analysis included 13 studies with 354 patients. The mean age was 71.3 years (95% CI 64.9 to 73.1), and 77% (95% CI 71.2% to 82.4%) were male. The mean follow-up time was 2.6 months (95% CI 1 to 15.3). Strategy success was seen in 88.7% (95% CI 82.3 to 95.1) of patients. The mean minimal stent area was reported in 6 studies, the pre-IVL value was 3.4 mm

Identifiants

pubmed: 37611414
pii: S0002-9149(23)00716-6
doi: 10.1016/j.amjcard.2023.07.144
pii:
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

223-230

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no competing interests to declare.

Auteurs

Rodolfo Caminiti (R)

Cardiology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Giampaolo Vetta (G)

Cardiology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Antonio Parlavecchio (A)

Cardiology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Alfonso Ielasi (A)

Cardiology Division, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Galeazzi Sant'Ambrogio, Milan, Italy.

Michele Magnocavallo (M)

Department of Cardiovascular, Respiratory, Nephrological, Anesthesiological and Geriatric Sciences, "Sapienza" University of Rome, Policlinico Umberto I, Rome, Italy.

Domenico Giovanni Della Rocca (DG)

Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas; Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Brussels, Belgium.

Enrico Cerrato (E)

Interventional Cardiology Unit, San Luigi Gonzaga University Hospital of Orbassano and Rivoli Infermi Hospital of Rivoli, Turin, Italy.

Scipione Carerj (S)

Cardiology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Gianluca Di Bella (G)

Cardiology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Antonio Micari (A)

Cardiology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Giampiero Vizzari (G)

Cardiology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. Electronic address: giampierovizzari@hotmail.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH